VVVaxxinity, Inc.
0.000100USDD
0.0000000.00%
Last update at 17:42 GMT
USD
No tradesPost-market
Next report date
≈
August 6
Report period
Q1 2025
EPS estimate
—
Revenue estimate
—
60.28 M
About Vaxxinity, Inc.
Sector
Industry
CEO
Mei Mei Hu
Website
Headquarters
Exploration Park
Founded
2014
FIGI
BBG012X4TKM9
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer’s, Parkinson’s, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.
No data available
There's currently no revenue data to show for the selected period.
No news here
Looks like there's nothing to report right now
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VAXX is 0.000100 USD — it hasn't changed in the past 24 hours. Watch Vaxxinity, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Vaxxinity, Inc. stocks are traded under the ticker VAXX.
VAXX stock hasn't changed in a week, the last month showed zero change in price, over the last year Vaxxinity, Inc. has showed a −99.96% decrease.
VAXX reached its all-time high on Nov 11, 2021 with the price of 22.770000 USD, and its all-time low was 0.000001 USD and was reached on Aug 29, 2024. View more price dynamics on VAXX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VAXX stock is 42.90 K% volatile and has beta coefficient of −31.88. Track Vaxxinity, Inc. stock price on the chart and check out the list of the most volatile stocks — is Vaxxinity, Inc. there?
Yes, you can track Vaxxinity, Inc. financials in yearly and quarterly reports right on TradingView.
Vaxxinity, Inc. is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
No, VAXX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VAXX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vaxxinity, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vaxxinity, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vaxxinity, Inc. stock shows the sell signal. See more of Vaxxinity, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.